Complete Filing Data
Quince Therapeutics, Inc. reported Stockholders Equity of $100.59 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Quince Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$56.8M | -$31.4M | -$51.7M | -$89.9M | -$76.8M | -$37.0M | -$12.5M |
| Research And Development Expense | $18.6M | $9.4M | $25.2M | $60.8M | $61.3M | $30.2M | $10.1M |
| Operating Income Loss | -$57.3M | -$34.6M | -$52.0M | -$90.3M | -$78.9M | -$39.2M | -$12.1M |
| Operating Expenses | $57.3M | $34.6M | $52.0M | $90.3M | $78.9M | $39.2M | $12.1M |
| General And Administrative Expense | $17.6M | $17.7M | $26.0M | $29.5M | $17.6M | $9.0M | $2.0M |
| Comprehensive Income Net Of Tax | -$59.9M | -$28.0M | -$51.9M | -$90.3M | -$76.6M | -$36.9M | -$12.5M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | $78.0K | $547.0K | -$458.0K | -$412.0K | $253.0K | $109.0K | -$49.0K |
| Other Nonoperating Income Expense | -$676.0K | -$102.0K | -$997.0K | -$247.0K | $0.00 | $0.00 | |
| Income Tax Expense Benefit | $87.0K | -$197.0K | -$284.0K | $0.00 | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$3.2M | $2.8M | $248.0K | $20.0K | $0.00 | $0.00 | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $253.0K | $109.0K | -$49.0K | ||||
| Deferred Income Tax Liabilities Net | $5.3M | $248.0K | $0.00 | ||||
| Impairment Of Intangible Assets Excluding Goodwill | $0.00 | $5.9M | $0.00 | ||||
| Operating Lease Impairment Loss | $0.00 | $66.0K | $136.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$13.4M | -$16.0M | -$15.0M | -$5.5M | -$27.7M | -$11.1M | -$5.4M | -$4.9M | -$12.3M | -$7.9M | -$16.6M | -$21.6M | -$21.7M | -$21.8M | -$23.1M | -$21.5M | -$17.6M | -$17.2M | -$9.9M | -$9.1M | -$5.7M | -$2.5M | -$3.1M | -$3.4M | |
| Research And Development Expense | $8.1M | $6.6M | $8.1M | $4.9M | $4.1M | $3.7M | $1.4M | $1.4M | $3.2M | $2.5M | $7.2M | $12.8M | $14.0M | $14.7M | $16.8M | $17.0M | $14.1M | $14.4M | $8.3M | $7.1M | $4.8M | $2.3M | $2.3M | $2.4M | |
| Operating Income Loss | -$13.4M | -$10.4M | -$14.9M | -$5.9M | -$28.2M | -$11.2M | -$6.1M | -$5.6M | -$13.0M | -$7.6M | -$16.3M | -$21.9M | -$21.7M | -$21.8M | -$23.3M | -$21.9M | -$18.3M | -$17.9M | -$10.6M | -$9.6M | -$6.1M | -$2.9M | -$2.6M | -$2.8M | |
| Operating Expenses | $13.4M | $10.4M | $14.9M | $5.9M | $28.2M | $11.2M | $6.1M | $5.6M | $13.0M | $7.6M | $16.3M | $21.9M | $21.7M | $21.8M | $23.3M | $21.9M | $18.3M | $17.9M | $10.6M | $9.6M | $6.1M | $2.9M | $2.6M | $2.8M | |
| General And Administrative Expense | $3.3M | $3.3M | $4.8M | $3.6M | $4.7M | $5.0M | $4.7M | $4.2M | $3.8M | $4.3M | $9.1M | $9.1M | $7.6M | $7.1M | $6.5M | $4.9M | $4.2M | $3.5M | $2.3M | $2.5M | $1.3M | $584.0K | $357.0K | $347.0K | |
| Comprehensive Income Net Of Tax | -$13.3M | -$11.9M | -$13.0M | -$3.2M | -$28.5M | -$12.4M | -$5.1M | -$4.7M | -$11.9M | -$7.7M | -$16.5M | -$22.1M | -$21.8M | -$21.8M | -$23.2M | -$21.7M | -$16.9M | -$17.3M | -$9.8M | -$9.0M | -$5.7M | -$2.5M | -$3.1M | -$3.4M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | $12.0K | -$17.0K | -$53.0K | $174.0K | -$12.0K | $7.0K | $101.0K | $160.0K | $235.0K | -$130.0K | -$210.0K | -$313.0K | -$64.0K | -$72.0K | -$124.0K | -$198.0K | $748.0K | -$97.0K | $16.0K | $103.0K | $26.0K | -$16.0K | |||
| Other Nonoperating Income Expense | -$58.0K | -$29.0K | -$87.0K | $150.0K | $91.0K | -$399.0K | -$216.0K | -$107.0K | -$246.0K | -$616.0K | -$735.0K | $150.0K | -$157.0K | -$131.0K | $0.00 | $0.00 | $0.00 | ||||||||
| Income Tax Expense Benefit | -$46.0K | $67.0K | $47.0K | $13.0K | $36.0K | $31.0K | $0.00 | $0.00 | -$248.0K | $0.00 | -$284.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.2M | -$726.0K | -$1.2M | $158.0K | $59.0K | $92.0K | $343.0K | $250.0K | -$114.0K | $18.0K | $0.00 | $0.00 | |||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$130.0K | -$210.0K | -$64.0K | -$72.0K | -$124.0K | -$198.0K | $748.0K | -$97.0K | $16.0K | $103.0K | $26.0K | -$16.0K | |||||||||||||
| Deferred Income Tax Liabilities Net | $5.6M | $5.6M | $5.2M | $5.0M | $5.4M | $5.2M | $5.2M | $0.00 | $0.00 | $0.00 | $248.0K | $248.0K | |||||||||||||
| Impairment Of Intangible Assets Excluding Goodwill | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.9M | $0.00 | $0.00 | |||||||||||||||||
| Operating Lease Impairment Loss | $0.00 | $66.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $100.6M | $118.6M | $172.3M | $115.5M | -$32.6M | -$20.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $44.6M | $69.7M | $66.8M | $51.2M | $24.9M | $7.4M | ||
| Operating Lease Right Of Use Asset | $385.0K | $291.0K | $1.2M | $674.0K | $625.0K | |||
| Common Stock Value | $43.0K | $36.0K | $30.0K | $29.0K | $27.0K | $3.0K | ||
| Retained Earnings Accumulated Deficit | -$319.6M | -$288.3M | -$236.6M | -$146.7M | -$69.8M | -$32.8M | ||
| Property Plant And Equipment Net | $234.0K | $393.0K | $263.0K | $427.0K | $709.0K | $283.0K | ||
| Prepaid Expense And Other Assets Current | $2.4M | $3.6M | $4.9M | $4.0M | $6.2M | $868.0K | ||
| Liabilities Current | $9.6M | $3.1M | $14.2M | $17.0M | $8.9M | $1.5M | ||
| Liabilities And Stockholders Equity | $167.9M | $103.9M | $133.2M | $189.5M | $124.4M | $72.9M | ||
| Liabilities | $82.8M | $3.3M | $14.6M | $17.2M | $8.9M | $1.5M | ||
| Assets Current | $77.4M | $93.7M | $111.7M | $137.9M | $106.1M | $72.6M | ||
| Assets | $167.9M | $103.9M | $133.2M | $189.5M | $124.4M | $72.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.0M | -$289.0K | -$79.0K | $313.0K | $60.0K | -$49.0K | ||
| Accrued Liabilities Current | $3.4M | $2.5M | $9.3M | $13.4M | $5.8M | $962.0K | ||
| Accounts Payable Current | $2.0M | $570.0K | $4.9M | $3.6M | $3.1M | $495.0K | ||
| Other Assets Noncurrent | $8.5M | $0.00 | $194.0K | $39.0K | $217.0K | $10.0K | ||
| Available For Sale Securities Debt Securities Current | $34.6M | $54.3M | $45.6M | $37.1M | $67.0M | $48.7M | $46.8M | |
| Additional Paid In Capital Common Stock | $406.6M | $401.6M | $389.1M | $355.2M | $318.6M | $185.2M | $245.0K | |
| Operating Lease Liability Noncurrent | $321.0K | $0.00 | $420.0K | $208.0K | ||||
| Finance Lease Principal Payments | $0.00 | $6.0K | $49.0K | $0.00 | $34.0K | $559.0K | ||
| Available For Sale Securities Debt Securities Noncurrent | $0.00 | $3.6M | $19.9M | $50.5M | $16.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.5M | -$23.8M | -$25.1M | $2.9M | $15.6M | $26.3M | ||
| Non Cash Rent Expense | $0.00 | -$29.0K | $199.0K | $367.0K | $367.0K | $153.0K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |||||
| Intangible Assets Net Excluding Goodwill | $63.7M | $5.9M | $0.00 | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $216.0K | $0.00 | $1.3M | $620.0K | $878.0K | |||
| Cash And Cash Equivalents At Carrying Value | $24.9M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $15.6M | $26.3M | $17.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.1M | $11.7M | $18.6M | $30.1M | $44.9M | $47.0M | $74.2M | $85.1M | $83.1M | $86.9M | $90.2M | $104.5M | $111.5M | $106.4M | $132.7M | $142.1M | $156.5M | $188.0M | $205.5M | $218.0M | $127.3M | $136.2M | -$38.0M | -$29.3M | -$26.7M | -$23.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.5M | $16.8M | $7.8M | $6.2M | $2.7M | $7.9M | $21.8M | $20.8M | $21.6M | $22.7M | $46.7M | $31.8M | $46.9M | $67.6M | $62.2M | $74.0M | $85.3M | $64.2M | $66.2M | $85.6M | $45.0M | $44.6M | $20.9M | $27.3M | $77.5M | $4.5M | |
| Operating Lease Right Of Use Asset | $481.0K | $507.0K | $493.0K | $498.0K | $559.0K | $554.0K | $498.0K | $48.0K | $110.0K | $171.0K | $208.0K | $328.0K | $343.0K | $1.4M | $1.5M | $500.0K | $848.0K | $686.0K | $637.0K | $815.0K | |||||||
| Common Stock Value | $54.0K | $53.0K | $44.0K | $44.0K | $43.0K | $43.0K | $43.0K | $6.5M | $36.0K | $36.0K | $36.0K | $36.0K | $36.0K | $30.0K | $30.0K | $30.0K | $29.0K | $29.0K | $29.0K | $29.0K | $27.0K | $27.0K | $4.0K | ||||
| Retained Earnings Accumulated Deficit | -$421.0M | -$407.6M | -$391.5M | -$376.5M | -$364.0M | -$358.5M | -$330.8M | -$310.8M | -$305.4M | -$300.5M | -$282.7M | -$274.8M | -$258.2M | -$213.2M | -$191.5M | -$169.7M | -$126.1M | -$104.6M | -$87.0M | -$57.4M | -$47.6M | -$38.5M | |||||
| Property Plant And Equipment Net | $616.0K | $573.0K | $448.0K | $315.0K | $208.0K | $246.0K | $234.0K | $5.0K | $6.0K | $6.0K | $375.0K | $364.0K | $230.0K | $303.0K | $390.0K | $378.0K | $500.0K | $565.0K | $624.0K | $270.0K | $265.0K | $314.0K | |||||
| Prepaid Expense And Other Assets Current | $2.9M | $2.6M | $2.2M | $3.3M | $3.9M | $4.0M | $2.6M | $1.4M | $983.0K | $2.3M | $3.9M | $4.7M | $4.8M | $5.0M | $5.9M | $2.9M | $5.2M | $7.1M | $6.2M | $3.6M | $5.1M | $4.5M | |||||
| Liabilities Current | $26.0M | $7.5M | $8.4M | $7.3M | $5.4M | $10.3M | $9.8M | $2.3M | $2.0M | $3.1M | $4.9M | $6.0M | $9.7M | $14.2M | $18.5M | $17.9M | $16.4M | $13.7M | $13.1M | $6.1M | $7.0M | $4.0M | |||||
| Liabilities And Stockholders Equity | $109.9M | $117.2M | $107.1M | $114.5M | $126.5M | $134.8M | $159.3M | $85.4M | $88.8M | $93.3M | $109.8M | $117.9M | $116.1M | $147.4M | $161.4M | $174.5M | $204.7M | $219.2M | $231.2M | $133.4M | $143.2M | $70.6M | |||||
| Liabilities | $108.8M | $105.5M | $88.5M | $84.3M | $81.6M | $87.9M | $85.1M | $2.3M | $2.0M | $3.1M | $5.2M | $6.3M | $9.8M | $14.8M | $19.3M | $18.0M | $16.7M | $13.7M | $13.2M | $6.1M | $7.0M | $4.5M | |||||
| Assets Current | $29.2M | $37.3M | $33.8M | $44.0M | $51.7M | $63.4M | $70.4M | $85.2M | $88.5M | $92.5M | $98.3M | $99.4M | $96.4M | $119.4M | $135.8M | $149.9M | $143.0M | $151.6M | $168.6M | $124.4M | $133.6M | $63.8M | |||||
| Assets | $109.9M | $117.2M | $107.1M | $114.5M | $126.5M | $134.8M | $159.3M | $85.4M | $88.8M | $93.3M | $109.8M | $117.9M | $116.1M | $147.4M | $161.4M | $174.5M | $204.7M | $219.2M | $231.2M | $133.4M | $143.2M | $70.6M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.3M | $6.2M | $2.0M | -$35.0K | $3.4M | $1.1M | $1.8M | $516.0K | $257.0K | $38.0K | -$253.0K | -$466.0K | -$506.0K | $71.0K | $117.0K | $189.0K | $513.0K | $711.0K | -$37.0K | $96.0K | $80.0K | -$23.0K | |||||
| Accrued Liabilities Current | $5.1M | $5.7M | $5.3M | $4.4M | $3.8M | $2.9M | $3.0M | $1.8M | $1.6M | $1.5M | $3.8M | $4.1M | $6.0M | $11.3M | $11.3M | $15.0M | $12.1M | $8.6M | $8.2M | $3.8M | $1.9M | $1.7M | |||||
| Accounts Payable Current | $3.4M | $1.8M | $3.0M | $2.9M | $1.6M | $2.4M | $2.1M | $409.0K | $353.0K | $1.7M | $1.2M | $1.9M | $3.7M | $2.9M | $7.2M | $2.8M | $4.3M | $5.1M | $5.0M | $2.3M | $5.1M | $1.9M | |||||
| Other Assets Noncurrent | $11.9M | $11.2M | $10.0M | $9.6M | $9.5M | $8.8M | $8.5M | $17.0K | $47.0K | $29.0K | $193.0K | $145.0K | $39.0K | $209.0K | $244.0K | $217.0K | $263.0K | $260.0K | $261.0K | ||||||||
| Available For Sale Securities Debt Securities Current | $45.2M | $51.6M | $46.0M | $61.6M | $64.9M | $43.5M | $62.5M | $47.7M | $24.0M | $52.2M | $55.9M | $61.7M | $73.5M | $78.3M | $76.8M | $75.7M | $84.0M | $38.4M | |||||||||
| Additional Paid In Capital Common Stock | $405.5M | $404.4M | $403.1M | $393.3M | $392.0M | $390.6M | $387.5M | $386.8M | $365.1M | $345.8M | $333.4M | $326.0M | $313.6M | $309.3M | $305.0M | $184.6M | $183.7M | $498.0K | |||||||||
| Operating Lease Liability Noncurrent | $359.0K | $387.0K | $383.0K | $394.0K | $450.0K | $453.0K | $394.0K | $34.0K | $95.0K | $40.0K | $610.0K | $773.0K | $171.0K | $244.0K | $50.0K | $57.0K | $475.0K | ||||||||||
| Finance Lease Principal Payments | $0.00 | $6.0K | $0.00 | $29.0K | |||||||||||||||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $0.00 | $0.00 | $475.0K | $5.0M | $11.0M | $19.2M | $26.1M | $23.5M | $23.7M | $60.1M | $66.1M | $61.1M | $7.3M | $8.0M | $5.4M | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.6M | $1.1M | $2.1M | -$2.2M | $18.5M | ||||||||||||||||||||||
| Non Cash Rent Expense | $0.00 | $92.0K | $92.0K | $92.0K | |||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Intangible Assets Net Excluding Goodwill | $67.7M | $67.6M | $62.4M | $60.0M | $64.5M | $61.8M | $62.3M | $0.00 | $0.00 | $0.00 | $5.9M | $5.9M | |||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $227.0K | $122.0K | $815.0K | |||||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $6.5M | $16.8M | $7.8M | $6.2M | $64.2M | $66.2M | $85.6M | $51.2M | $44.7M | $44.3M | $20.6M | $27.3M | $77.5M | $4.4M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $18.5M | $34.4M | -$4.0M | -$2.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $4.7M | $5.2M | $16.6M | $29.9M | $14.5M | $2.1M | $155.0K |
| Net Cash Provided By Used In Operating Activities | -$31.9M | -$18.3M | -$44.0M | -$62.9M | -$50.8M | -$33.3M | -$11.7M |
| Net Cash Provided By Used In Financing Activities | -$4.8M | $143.0K | $707.0K | $6.8M | $118.9M | $77.4M | $75.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.7M | -$4.2M | -$2.6M | $829.0K | -$2.2M | $5.3M | $690.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $1.2M | -$2.0M | -$6.7M | -$4.6M | $7.4M | $4.9M | $273.0K |
| Increase Decrease In Accounts Payable | $927.0K | -$288.0K | -$5.9M | $1.4M | $480.0K | $2.6M | -$23.0K |
| Payments To Acquire Property Plant And Equipment | $257.0K | $160.0K | $133.0K | $180.0K | $52.0K | $55.0K | $212.0K |
| Net Cash Provided By Used In Investing Activities | $21.9M | -$5.8M | $18.0M | $59.0M | -$52.4M | -$17.7M | -$46.8M |
| Proceeds From Stock Options Exercised | $225.0K | $149.0K | $148.0K | $6.8M | $1.3M | $97.0K | $24.0K |
| Payments To Acquire Investments | $113.8M | $75.0M | $38.8M | $187.1M | $135.4M | $55.2M | |
| Proceeds From Sale Maturity And Collections Of Investments | $111.2M | $82.5M | $97.9M | $134.8M | $117.7M | $8.7M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $231.0K | $80.0K | $184.0K | $55.0K | $0.00 | $0.00 | |
| Increase Decrease In Other Current Assets | $741.0K | $9.0K | -$194.0K | $155.0K | |||
| Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period | $225.0K | $167.0K | $148.0K | ||||
| Proceeds From Sale Of Productive Assets | $0.00 | $90.0K | $70.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.4M | $1.3M | $1.5M | $9.2M | $7.0M | $2.0M | $190.0K | $13.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$9.6M | -$8.4M | -$3.6M | -$16.1M | -$13.6M | -$10.8M | -$7.2M | -$3.2M | ||||||
| Net Cash Provided By Used In Financing Activities | $87.0K | $190.0K | $50.0K | $622.0K | $441.0K | $117.9M | $64.0K | $238.0K | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$944.0K | $440.0K | -$1.4M | -$42.0K | -$1.2M | -$49.0K | $3.6M | $80.0K | ||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $898.0K | -$381.0K | -$844.0K | -$2.9M | $1.6M | $2.3M | $762.0K | -$276.0K | ||||||
| Increase Decrease In Accounts Payable | $22.0K | $59.0K | $1.1M | -$1.2M | -$710.0K | $1.9M | $1.5M | -$82.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $148.0K | $39.0K | $136.0K | $5.0K | $37.0K | $5.0K | $51.0K | |||||||
| Net Cash Provided By Used In Investing Activities | $10.9M | $8.9M | $5.5M | $13.4M | $31.6M | -$72.7M | $3.2M | |||||||
| Proceeds From Stock Options Exercised | $87.0K | $190.0K | $56.0K | $14.0K | $441.0K | $191.0K | $64.0K | |||||||
| Payments To Acquire Investments | $39.3M | $7.7M | $9.0M | $12.0M | $95.5M | $25.6M | ||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $48.2M | $13.3M | $22.4M | $43.7M | $22.9M | $28.8M | ||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $175.0K | $310.0K | $114.0K | -$104.0K | $0.00 | |||||||||
| Increase Decrease In Other Current Assets | -$163.0K | $8.0K | $0.00 | -$165.0K | ||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period | $96.0K | $35.0K | $190.0K | $28.0K | $27.0K | $56.0K | $13.0K | $121.0K | ||||||
| Proceeds From Sale Of Productive Assets | $0.00 | $90.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.31 | -$0.84 | -$1.54 | -$3.03 | -$2.63 | -$1.94 | -$3.71 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 43.0M | 36.1M | 30.1M | 29.5M | 26.9M | 3.4M | |
| Common Stock Shares Issued | 43.0M | 36.1M | 30.1M | 29.5M | 26.9M | 3.4M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 24.8M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 43.3M | 37.2M | 33.5M | 29.7M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 43.3M | 37.2M | 33.5M | 29.7M | |||
| Earnings Per Share Basic | $-1.31 | $-0.84 | $-1.54 | $-3.03 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.7M | 29.2M | 19.0M | 3.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.25 | -$0.34 | -$0.34 | -$0.13 | -$0.64 | -$0.26 | -$0.15 | -$0.14 | -$0.34 | -$0.22 | -$0.51 | -$0.72 | -$0.73 | -$0.74 | -$0.78 | -$0.73 | -$0.60 | -$0.61 | -$0.37 | -$0.57 | -$1.61 | -$0.75 | -$0.93 | -$1.01 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 54.5M | 53.6M | 44.1M | 44.0M | 43.3M | 43.3M | 43.2M | 36.3M | 36.3M | 36.3M | 36.1M | 36.0M | 30.1M | 29.9M | 29.7M | 29.6M | 29.5M | 29.5M | 29.4M | 26.8M | 26.8M | 3.6M | |||
| Common Stock Shares Issued | 54.5M | 53.6M | 44.1M | 44.0M | 43.3M | 43.3M | 43.2M | 36.3M | 36.3M | 36.3M | 36.1M | 36.0M | 30.1M | 29.9M | 29.7M | 29.6M | 29.5M | 29.5M | 29.4M | 26.8M | 26.8M | 3.6M | |||
| Common Stock Shares Authorized | 250.0M | 250.0M | 100.0M | 250.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 24.8M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 54.0M | 46.7M | 43.9M | 43.2M | 43.1M | 43.0M | 36.1M | 35.9M | 35.9M | 35.6M | 32.5M | 30.1M | 29.8M | 29.6M | |||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 54.0M | 46.7M | 43.9M | 43.2M | 43.1M | 43.0M | 36.1M | 35.9M | 35.9M | 35.6M | 32.5M | 30.1M | 29.8M | 29.6M | |||||||||||
| Earnings Per Share Basic | $-0.25 | $-0.34 | $-0.34 | $-0.13 | $-0.64 | $-0.26 | $-0.15 | $-0.14 | $-0.34 | $-0.22 | $-0.51 | $-0.72 | $-0.73 | $-0.74 | |||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.1M | 29.8M | 29.6M | 29.6M | 29.5M | 29.4M | 28.3M | 26.8M | 15.8M | 3.5M | 3.4M | 3.4M | 3.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.7M | $5.2M | $16.6M | $29.9M | $14.5M | $2.1M | $155.0K |
| Investment Income Interest | $2.9M | $3.5M | $1.1M | $620.0K | $2.0M | $2.2M | $806.0K |
| Depreciation And Amortization | $186.0K | $322.0K | $204.0K | $344.0K | $332.0K | $188.0K | $51.0K |
| Investment Income Net Amortization Of Discount And Premium | $2.3M | $2.0M | $113.0K | -$878.0K | -$635.0K | $812.0K | $351.0K |
| Stock Issued During Period Value Stock Options Exercised | $6.8M | $1.3M | $97.0K | $24.0K | |||
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$56.7M | -$31.6M | -$51.9M | $0.00 | |||
| Stock Issued During Period Value New Issues | $608.0K | $117.6M | $77.8M | ||||
| Loss On Disposal | $0.00 | $37.0K | $94.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $1.3M | $1.4M | $1.1M | $1.2M | $1.3M | $1.3M | $1.3M | $1.5M | $694.0K | $5.1M | $9.2M | $7.6M | $6.8M | $7.0M | $4.2M | $3.4M | $2.0M | $912.0K | $377.0K | $190.0K | $20.0K | $14.0K | $13.0K |
| Investment Income Interest | $300.0K | $311.0K | $406.0K | $683.0K | $823.0K | $887.0K | $959.0K | $805.0K | $700.0K | $315.0K | $145.0K | $72.0K | $128.0K | $160.0K | $227.0K | $406.0K | $659.0K | $682.0K | $711.0K | $513.0K | $394.0K | $353.0K | $81.0K | |
| Depreciation And Amortization | $32.0K | $40.0K | $17.0K | $38.0K | $86.0K | $83.0K | $19.0K | $8.0K | ||||||||||||||||
| Investment Income Net Amortization Of Discount And Premium | $355.0K | $646.0K | $139.0K | -$135.0K | -$202.0K | -$56.0K | $171.0K | |||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $87.0K | $190.0K | $14.0K | $4.7M | $672.0K | $441.0K | $90.0K | $954.0K | $191.0K | $5.0K | $64.0K | |||||||||||||
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$13.5M | -$16.0M | -$5.5M | -$27.7M | -$11.1M | -$5.4M | -$4.9M | -$12.5M | -$7.9M | -$16.8M | -$21.6M | -$21.7M | -$21.8M | |||||||||||
| Stock Issued During Period Value New Issues | $608.0K | -$62.0K | $117.7M | $77.8M | ||||||||||||||||||||
| Loss On Disposal | $0.00 | $73.0K | $0.00 |
Most recent annual filing with the SEC: March 24, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.